Company intelligence / Profile preview

Evasc Neurovascular

Vancouver, British Columbia, Canada

Ownership: Private
Development stage: Other

Overview

Evasc Neurovascular has developed and commercialized the eCLIPs Aneurysm Treatment System, including second-generation electrolytic eCLIPs implants (eB) and the higher-coverage eCLIPs bifurcation flow diverter (eBFD), with real‑world registry data in >280 patients showing high satisfactory (≈96%) and complete occlusion rates and favorable safety in the treatment of wide-neck bifurcation aneurysms.[3][5][6][12] The company is running the prospective EESIS-France (EESIS-FR) study to further validate safety, feasibility, and efficacy, and has reported milestones such as 120+ successful cerebral aneurysm cases and strong adoption in Europe.[1][5][7][8]

Therapeutic areas: Neurology
Modalities: Device
Industry: Implantable Medical Devices

Beyond the preview

Go deeper on Evasc Neurovascular.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Evasc Neurovascular.

Explore the full profile